Article Details

AstraZeneca buys EsoBiotec for $1 B to advance cell therapy ambition - BioSpectrum Asia

Retrieved on: 2025-03-17 14:12:41

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca buys EsoBiotec for $1 B to advance cell therapy ambition - BioSpectrum Asia. View article details on hiswai:

Excerpt

British pharmaceutical firm AstraZeneca has entered into a definitive agreement to acquire Belgium-based biotech startup EsoBiotec.

Article found on: www.biospectrumasia.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up